A possible explanation for the lack of increased NLRP3 expression, despite elevated caspase-1, IL1β and IL18, is that only specific locations have cells with activated NLRP3 (i.e., a cluster of invading immune cells at the tumor/tissue interface) and tissue was from regions without altered NLRP3. This evidence concerns the gene CASP1 and neoplasm.